Nanobiotix launches global offering
This fundraising will be completed by a private placement, reserved for Johnson & Johnson, the French biotech company's industrial partner, for an amount of $25 million.
'Nanobiotix shares will be suspended from trading on Euronext this November 2 until the opening of trading of Nanobiotix ADSs on Nasdaq, at around 2:30 pm (Paris time)', says the company.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction